
|Articles|October 1, 2012
Ongoing botulinum injections' efficacy in question
The treatment benefit of intradetrusor onabotulinumtoxinA (Botox) for urinary incontinence due to neurogenic detrusor overactivity may decline after patients have received multiple repeat injections, findings from a study by Taiwanese urologists suggest.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants fast track designation to Enolen for localized prostate cancer
2
High PHI scores are linked to increased odds of significant prostate cancer
3
Trial to evaluate novel combination in BCG-unresponsive NMIBC
4
Dosing begins in trial of alpha radioligand therapy for mCRPC
5




















